Anti-Inflammatory Drugs Market
                     Title : Anti-Inflammatory Drugs Market to Rise at 9.3% CAGR, Rising Prevalence of Atopic  
Dermatitis to Favor Market Growth
Anti-Inflammatory Drugs Market to Exhibit 9.3% CAGR by 2027 Owing to Rising Prevalence  
of Inflammatory Health Conditions
Description : Anti-Inflammatory Drugs Market to Rise Remarkably by 2027, Favorable  
Government Initiatives to Launch Biosimilars will Add Impetus to the Market: Fortune  
Business Insights™
Content :
The global anti-inflammatory market size is expected to reach USD 191.42 billion by 2027 on  
account of increasing investments on the development of biologics for treating autoimmune  
inflammatory diseases. Anti-inflammatory drugs help to reduce inflammation in the body  
and treat health conditions such as arthritis, asthma, rheumatoid arthritis, sinusitis, and  
others. A recently published report by Fortune Business Insights offers a comprehensive  
overview of the market and its prime growth trajectories. As per the report titled, “Anti-  
Inflammatory Drugs Market Size, Share & Industry Analysis, By Drug Class (Anti-  
inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids),  
By Application (Autoimmune Inflammatory Diseases (Rheumatoid Arthritis Psoriasis, and  
Others), Respiratory Diseases, and Others), By Route of Administration (Oral, Injection,  
Inhalation, and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy,  and 
Online Pharmacy), and Regional Forecast, 2020-2027,” the value of the market was  USD 
93.88 billion in 2019 and is expected to rise at a CAGR of 9.3% between 2020 to 2027.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this  
health crisis has brought an unprecedented impact on businesses across industries.
However, this too shall pass. Rising support from governments and several companies can  
help in the fight against this highly contagious disease. There are some industries that are  
struggling and some are thriving. Overall, almost every sector is anticipated to be impacted  
by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19  
pandemics. Based on our experience and expertise, we will offer you an impact analysis of  
corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/anti-inflammatory-drugs-  
market-102825
What are the Objectives of the Report?
The report offers a comprehensive overview of the market and its growth parameters such  
as drivers, restraints, challenges, and upcoming opportunities. The report also offers  
interesting insights into the market, current trends, and significant industry developments.  It 
also throws light on key players functioning in the market and the key strategies adopted  by 
them to compete for the top position. The report further discusses the segmentation of  the 
market based on factors such as drug-class, application, route of administration,  distribution 
channel, and geography, and lists the names of the leading segment with  attributed factors. 
The report offers an overall qualitative and quantitative analysis of the  market and is 
available for sale on the company website.
Market Drivers
Increasing Prevalence of Inflammatory Diseases will Add Impetus to Market
The increasing prevalence of inflammatory diseases namely ulcerative colitis, inflammatory  
bowel, psoriasis, and rheumatoid arthritis, and othersare the major anti-inflammatory drugs  
market growth driver.As per the Centers for Disease Control and Prevention, an estimate of  
78 million people in the U.S. will be diagnosed with arthritis by the end of 2040. Apart from  
this, the increasing uptake of corticosteroids for treating chronic obstructive pulmonary  
diseases (COPD) and asthma, coupled with the increasing prevalence of atopic dermatitis  are 
likely to aid in the expansion of the market in the long run.
On the contrary, the side effects of using non-steroids anti-inflammatory drugs or NSAIDs  
such as dizziness, allergic reactions, stomach pain, stomach ulcers, and others may pose a  
major threat to the market in the coming years. This, coupled with the risk of  gastrointestinal 
bleeding and other complications may hinder the market in the coming  years.
Regional Segmentation
North America to Emerge Dominant with Favorable Reimbursement Policies
Geographically, the market is dominated by North America with the rising demand for anti-  
inflammatory biologics, and government support for their launches. In 2019, North America  
earned a revenue of USD 41.39 billion, attributed to the massive investments in research  
and development that further expanded the regional market. The market in Europe, on the  
other hand, is likely to witness significant growth on account of active government support  
for launching biosimilars, and favorable health reimbursement policies. Moreover, the  
market in Asia Pacific will rise at a rapid speed on account of improving healthcare  
infrastructure and facilities, coupled with the increasing geriatric population, and rising  
preference for generic corticosteroids and NSAIDs. Furthermore, the Middle East and Latin  
American markets will gain momentum on account of the growing incidences of rheumatoid  
arthritis and improving healthcare infrastructure in the respective regions.
More Trending Topics from Fortune Business Insights:
Retinal Disease Therapeutics Market , Share, Growth, Sales and Drivers Analysis Research  
Report 2026
Retinal Disease Therapeutics Market to Reach US$ 21,318.0 Mn by 2026, Advancements in  
Retinal Disease Diagnosis Devices to Boost the Market, says Fortune Business Insights